Show Search Form
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Medical Treatments | ||||||||||||||
house id | 2 | ||||||||||||||
identifier | HL645 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 58 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask Her Majesty's Government which treatments NHS England's Clinical Priorities Advisory Group will be considering for prioritisation at its next meeting. | ||||||||||||||
session |
|
||||||||||||||
session number | 3 | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Lords Tabled Parliamentary Question 2022/23 HL645 | ||||||||||||||
type |
|
||||||||||||||
uin | HL645 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Non-tuberculous Mycobacteria | ||||||||||||||
house id | 2 | ||||||||||||||
identifier | HL646 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 58 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask Her Majesty's Government what assessment they have made of the impact on patients with non-tuberculous mycobacteria should there be a delay to the next meeting of the NHS England's Clinical Priorities Advisory Group. | ||||||||||||||
session |
|
||||||||||||||
session number | 3 | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Lords Tabled Parliamentary Question 2022/23 HL646 | ||||||||||||||
type |
|
||||||||||||||
uin | HL646 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Non-tuberculous Mycobacteria: Screening | ||||||||||||||
house id | 2 | ||||||||||||||
identifier | HL647 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 58 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask Her Majesty's Government what measures are in place to test patients treated with macrolide therapy for non-tuberculous mycobacteria; and how many of these tests have been undertaken in England. | ||||||||||||||
session |
|
||||||||||||||
session number | 3 | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Lords Tabled Parliamentary Question 2022/23 HL647 | ||||||||||||||
type |
|
||||||||||||||
uin | HL647 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Hereditary Angioedema: Medical Treatments | ||||||||||||||
house id | 2 | ||||||||||||||
identifier | HL648 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 58 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask Her Majesty's Government, further to their Vision for the Women's Health Strategy for England, published in December 2021, what assessment NHS England has made of the impact of long-term androgen use by women to treat hereditary angioedema (HAE); and how their use reflects women's needs. | ||||||||||||||
session |
|
||||||||||||||
session number | 3 | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Lords Tabled Parliamentary Question 2022/23 HL648 | ||||||||||||||
type |
|
||||||||||||||
uin | HL648 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Hereditary Angioedema: Diagnosis and Medical Treatments | ||||||||||||||
house id | 2 | ||||||||||||||
identifier | HL649 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 58 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask Her Majesty's Government how many people in England have been diagnosed with and are receiving treatment for hereditary angioedema. | ||||||||||||||
session |
|
||||||||||||||
session number | 3 | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Lords Tabled Parliamentary Question 2022/23 HL649 | ||||||||||||||
type |
|
||||||||||||||
uin | HL649 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Rare Diseases: Health Services | ||||||||||||||
house id | 2 | ||||||||||||||
identifier | HL650 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 58 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask Her Majesty's Government what steps they are taking (1) to improve access to specialist care, and (2) to reduce regional health inequalities, among patients with rare diseases, including those with hereditary angioedema. | ||||||||||||||
session |
|
||||||||||||||
session number | 3 | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Lords Tabled Parliamentary Question 2022/23 HL650 | ||||||||||||||
type |
|
||||||||||||||
uin | HL650 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Coronavirus: Notifiable Diseases | ||||||||||||||
house id | 2 | ||||||||||||||
identifier | HL1242 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 58 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask Her Majesty's Government whether COVID-19 is a notifiable disease; if so, (1) who is under a duty to make such notifications, and (2) to whom such notifications are made; whether the public are (a) under a duty, or (b) advised, to notify if they have COVID-19; and if so, who the public should notify. | ||||||||||||||
session |
|
||||||||||||||
session number | 3 | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Lords Tabled Parliamentary Question 2022/23 HL1242 | ||||||||||||||
type |
|
||||||||||||||
uin | HL1242 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Medical Treatments | ||||||||||||||
house id | 2 | ||||||||||||||
identifier | HL1396 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 58 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 17 June (HL645), whether an agenda for NHS England's Clinical Priorities Advisory Group's next meeting has been finalised; and if so, when the agenda will be shared with stakeholders. | ||||||||||||||
session |
|
||||||||||||||
session number | 3 | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Lords Tabled Parliamentary Question 2022/23 HL1396 | ||||||||||||||
type |
|
||||||||||||||
uin | HL1396 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Medical Treatments | ||||||||||||||
house id | 2 | ||||||||||||||
identifier | HL1440 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 58 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 17 June (HL645), whether an agenda for NHS England's Clinical Priorities Advisory Group's next meeting has been finalised; and if so, when it will be shared with relevant stakeholders. | ||||||||||||||
session |
|
||||||||||||||
session number | 3 | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Lords Tabled Parliamentary Question 2022/23 HL1440 | ||||||||||||||
type |
|
||||||||||||||
uin | HL1440 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Heart Diseases: Diagnosis and Medical Treatments | ||||||||||||||
house id | 2 | ||||||||||||||
identifier | HL1644 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 58 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask Her Majesty's Government what steps they will take to ensure that GP surgeries with low performing Quality and Outcomes Framework (QOF) data are provided with additional support for (1) diagnosing, and (2) treating, heart failure. | ||||||||||||||
session |
|
||||||||||||||
session number | 3 | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Lords Tabled Parliamentary Question 2022/23 HL1644 | ||||||||||||||
type |
|
||||||||||||||
uin | HL1644 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|